Trials / Conditions / Breast Carcinoma in Situ

Breast Carcinoma in Situ

11 registered clinical trials studyying Breast Carcinoma in Situ — 6 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	The Added Value of Contrast Enhanced Mammography to Standard Mammography in Assessing the Extent of DCIS NCT06217458	Clinical Hospital Center Rijeka	N/A
Enrolling By Invitation	Trastuzumab Plus Taxane Neoadjuvant Therapy for HER2-Positive Breast Ductal Carcinoma In Situ (DCIS) : A Phase NCT06843681	Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University	Phase 2
Recruiting	EXERT-BCH Exercise Regimen to Improve Muscle Mass After Treatment of Breast Cancer NCT06115486	Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)	N/A
Completed	Postoperative Pain After Breast Surgery Under Tumescent Local Anaesthesia Versus General Anaesthesia ( TLA-001 NCT06335108	University Hospital Tuebingen	—
Completed	An Integrated Optimization of Surgery and Radiotherapy Techniques to Improve Cosmetic Outcome and Quality of L NCT05263362	Erasmus Medical Center	—
Recruiting	Oncologic, Cosmetic and Patient Reported Outcomes in Value-Based Breast Surgery (OnCoPRO Value) NCT06401304	Uppsala University	—
Completed	Factors Affecting Functionality in Breast Cancer Survivors NCT04245657	Izmir Bakircay University	—
Recruiting	Registry for Intra-Operative Radiotherapy During Breast Conserving Surgery in Patients With Early Stage Breast NCT04603209	Saint John's Cancer Institute	—
Active Not Recruiting	Testing MK-3475 (Pembrolizumab) as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer NCT02954874	National Cancer Institute (NCI)	Phase 3
Recruiting	Women Informed to Screen Depending on Measures of Risk (Wisdom Study) NCT02620852	University of California, San Francisco	N/A
Completed	Immediate Breast Reconstruction With Acellular Dermal Matrix NCT04209010	Aarhus University Hospital	—